UK deal sees consolidation of two players in the iPSC space

Retrieved on: 2021-03-18 10:30:00

Tags for this article:

Click the tags to see associated articles and topics

UK deal sees consolidation of two players in the iPSC space. View article details on hiswai:

Excerpt

On that, Liam Taylor, CEO Axol, told BioPharma-Reporter: “Doubling the size of the scientific and technical project team and moving into two sites ...

Article found on: www.biopharma-reporter.com

View Original Article